세계의 미용 의료 시장 - 규모, 점유율 및 동향 분석 보고서 : 시술 유형별, 최종 사용자별, 지역별, 부문 예측(2025-2033년)

Aesthetic Medicine Market Summary

The global aesthetic medicine market size was estimated at USD 89.64 billion in 2024 and is projected to reach USD 239.98 billion by 2033, growing at a CAGR of 11.73% from 2025 to 2033. This growth can be attributed to the increasing adoption of minimally invasive and noninvasive procedures, coupled with the growth in the population prone to experiencing signs of aging.

As per the ISAPS report, a total of 17.42 million surgical procedures and 20.54 million non-surgical procedures were performed in 2024. Moreover, technological advancements, such as minimally invasive techniques, laser treatments, and injectables such as Botox and dermal fillers, have made cosmetic procedures safer and more accessible, encouraging more individuals to consider them. In addition, the increase in healthcare tourism and the availability of well-trained specialists in emerging markets also support the expansion of this market.

The increasing geriatric population across the globe is expected to drive the aesthetic medicine market. Major economies are undergoing a demographic shift due to a rapidly aging population, and the demand for cosmetic solutions is growing to combat the visible signs of aging and maintain a youthful appearance. This has led to a significant surge in demand for aesthetic medicines that effectively reduce wrinkles, fine lines, and other age-related concerns.

This demographic shift is expected to promote the development of innovative procedures, including aesthetic medicines, which cater to the needs of the rapidly aging population. This trend creates a favorable environment for the market to thrive and effectively meet the growing demand.

Global Aesthetic Medicine Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global aesthetic medicine market report based on procedure type, end use, and region:

• Procedure Type Outlook (Revenue, USD Billion, 2021 - 2033)
• Invasive Procedures
  • Breast augmentation
  • Liposuction
  • Nose reshaping
  • Eyelid Surgery
  • Tummy tuck
  • Others
• Non-invasive Procedures
  • Botox injections
  • Soft tissue fillers
  • Chemical peel
  • Laser hair removal
  • Microdermabrasion
  • Others
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
• Hospitals
• Clinics & Aesthetic Centers
• Medspas
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
  • 1.3.5. Details of Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
  • 1.5.1. Commodity Flow Analysis
• 1.6. Data Validation & Publishing
• 1.7. List of Secondary Sources
• 1.8. Research Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segmental Snapshot
• 2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

• 3.1. Market Lineage
  • 3.1.1. Parent Market Analysis
  • 3.1.2. Ancillary Market Analysis
• 3.2. Aesthetic Medicine Market- Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing geriatric population
    • 3.2.1.2. Increasing awareness and acceptance of aesthetic treatments
    • 3.2.1.3. Rising preference for minimally invasive procedures
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Stringent regulatory framework
    • 3.2.2.2. Complications related to liposuction and postoperative complications related to nose reshaping
• 3.3. Patient Perspective Analysis
  • 3.3.1. Consumer behavior analysis
  • 3.3.2. Market influencer analysis
• 3.4. Number of Plastic Surgeons in 2024
• 3.5. Major Deals & Strategic Alliances Analysis
• 3.6. Business Environmental Tools Analysis: Aesthetic Medicine Market
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTLE Analysis

Chapter 4. Aesthetic Medicine Market: Procedure Type Estimates & Trend Analysis

• 4.1. Aesthetic Medicine Market, By Procedure Type: Key Takeaways
• 4.2. Aesthetic Medicine Market: Procedure Type Movement & Market Share Analysis, 2024 & 2033
• 4.3. Invasive Procedures
  • 4.3.1. Invasive Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.3.2. Breast Augmentation
    • 4.3.2.1. Breast Augmentation Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.3.3. Liposuction
    • 4.3.3.1. Liposuction Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.3.4. Nose Reshaping
    • 4.3.4.1. Nose Reshaping Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.3.5. Eyelid Surgery
    • 4.3.5.1. Eyelid Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.3.6. Tummy Tuck
    • 4.3.6.1. Tummy Tuck Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.3.7. Others
    • 4.3.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 4.4. Non-invasive Procedures
  • 4.4.1. Non-invasive Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.2. Botox Injections
    • 4.4.2.1. Botox Injections Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.3. Soft Tissue Fillers
    • 4.4.3.1. Soft Tissue Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.4. Chemical Peel
    • 4.4.4.1. Chemical Peel Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.5. Laser Hair Removal
    • 4.4.5.1. Laser Hair Removal Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.6. Microdermabrasion
    • 4.4.6.1. Microdermabrasion Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.7. Others
    • 4.4.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Aesthetic Medicine Market: End Use Estimates & Trend Analysis

• 5.1. Aesthetic Medicine Market, By End Use: Key Takeaways
• 5.2. Aesthetic Medicine Market: End Use Movement & Market Share Analysis, 2024 & 2033
• 5.3. Hospitals
  • 5.3.1. Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.4. Clinics & Aesthetic Centers
  • 5.4.1. Clinics & Aesthetic Centers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.5. Medspas
  • 5.5.1. Medspas Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Aesthetic Medicine Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. North America
  • 6.4.1. U.S.
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.4.2. Canada
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.4.3. Mexico
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.5. Europe
  • 6.5.1. UK
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.2. Germany
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.3. France
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.4. Italy
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.5. Spain
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.6. Norway
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.7. Sweden
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.8. Denmark
    • 6.5.8.1. Key country dynamics
    • 6.5.8.2. Regulatory framework
    • 6.5.8.3. Competitive scenario
    • 6.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.6. Asia Pacific
  • 6.6.1. Japan
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.6.2. China
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.6.3. India
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.6.4. Australia
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.6.5. South Korea
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.6.6. Thailand
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Singapore market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.7. Latin America
  • 6.7.1. Brazil
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.7.2. Argentina
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.8. MEA
  • 6.8.1. South Africa
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.8.2. Saudi Arabia
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.8.3. UAE
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Competitive scenario
    • 6.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.8.4. Kuwait
    • 6.8.4.1. Key country dynamics
    • 6.8.4.2. Regulatory framework
    • 6.8.4.3. Competitive scenario
    • 6.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Key company market position analysis, 2024
• 7.4. List of Companies
  • 7.4.1. The Cosmetic Clinic (SILK Laser Australia Limited)
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Service benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Therapie Clinic /Valterous Limited.
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Service benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Skinotive Clinic
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Service benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Shea Aesthetic Clinic
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Service benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Sisu Clinic
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Service benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. THE BANGKOK COSMETIC CLINIC
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Service benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Cutis Medical Laser Clinics
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Service benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Grand Plastic Surgery
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Service benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. MUSE CITY CLINIC
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Service benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. The Esthetic Clinics
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Service benchmarking
    • 7.4.10.4. Strategic initiatives